MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical differences between Parkinson’s disease motor phenotypes. Results from the COPPADIS Study Cohort

I. Legarda Ramirez, B. Vives Pastor, M. Menéndez González, M. Blázquez Estrada, M. Seijo, M. Lage Castro, R. Vázquez Gómez, J. Ruíz Martínez, A. Bergareche Yarza, C. Valero, MM. Kurtis, JR. Pérez Sánchez, O. de Fábregues-Boixar, J. González Ardura, C. Prieto, C. Ordás Bandera, P. Mir, P. Martínez Martín, D. Santos García (Palma de Mallorca, Spain)

Meeting: 2018 International Congress

Abstract Number: 1597

Keywords: Bradykinesia, Cognitive dysfunction, Depression

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: To describe the prevalence of different motor phenotypes in a large cohort of Parkinson´s disease (PD) patients and to analyze their clinical features in detail.

Background: Different clinical phenotypes have been recognized in PD. Defining these subtypes clearly is needed to better understand underlying mechanisms and predict disease course.

Methods: The data were obtained from the baseline evaluation of the COPPADIS-Study, an observational, descriptive, 5-year follow-up, national (Spain), multicenter study (Santos García 2016). Three different motor phenotypes were considered─ Tremor Dominant (TD), Postural Instability Gait Difficulty (PIGD) and Indeterminate (ID) ─ based on a previously published formula (Jankovic 1990). Motor, non-motor, sociodemographic and PD-related variables were collected.

Results: Of 687 PD patients (62.8 ± 9 years old, 59.8% males) included, TD was the most frequent phenotype (45%), followed by PIGD (39.4%) and ID (15.6%). No differences in sex nor age were found between groups. TD patients presented lower non-motor symptoms burden compared to ID and PIGD (Non-Motor Symptoms Scale, 40.1 ± 34.8 vs 48.1 ± 37.3 vs 51.3 ± 41; p<0.0001), including lower pain scores (VAS-PAIN, 2.3 ± 2.8 vs 2.9 ± 3.1 vs 2.9 ± 3; p<0,0001) and lower fatigue scores (VAS-Fatigue, 2.4 ± 2.6 vs 3 ± 2.6 vs 3.6 ± 2.8; p<0,0001), better motor status (UPDRS part-III, 21.3 ± 10.6 vs 23.3 ± 10.9 vs 24.1 ± 12.2; p=0.02; UPDRS part-IV, 1.4 ± 1.9 vs 2.1 ± 2.5 vs 2.7 ± 2.6; p<0.0001) and better quality of life (QoL) (PDQ39, 14.6 ± 12.4 vs 19.4 ± 15.2 vs 19.1 ± 13.6; p<0.0001). On the contrary, the PIGD phenotype was associated to a longer disease duration compared to ID and TD (6.5 ± 4.6 years vs 5.6 ± 3.5 vs 4.7 ± 4.3; p<0.0001), more gait problems (Freezing of Gait Questionnaire, 5.4 ± 5.3 vs 3.8 ± 4.2 vs 2.3 ± 3.3; p<0.0001), depression (BDI-II, 10 ± 7.3 vs 8.7 ± 8.1 vs 7.8 ± 7.1; p<0.0001), neuropsychiatric symptoms (NPI, 7 ± 8.8 vs 5.5 ± 8.3 vs 5.6 ± 7.9; p<0,0001), and higher levodopa-equivalent daily dose (683.6 ± 469.3 vs 544.2 ± 349.3 vs 457.2 ± 353.6; p<0,0001).

Conclusions: According to previous studies, our findings suggest clear clinical differences between the defined PD motor phenotypes. While PIGD is the most severe phenotype, TD is the most benign with less motor and non-motor burden and better QoL.

To cite this abstract in AMA style:

I. Legarda Ramirez, B. Vives Pastor, M. Menéndez González, M. Blázquez Estrada, M. Seijo, M. Lage Castro, R. Vázquez Gómez, J. Ruíz Martínez, A. Bergareche Yarza, C. Valero, MM. Kurtis, JR. Pérez Sánchez, O. de Fábregues-Boixar, J. González Ardura, C. Prieto, C. Ordás Bandera, P. Mir, P. Martínez Martín, D. Santos García. Clinical differences between Parkinson’s disease motor phenotypes. Results from the COPPADIS Study Cohort [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/clinical-differences-between-parkinsons-disease-motor-phenotypes-results-from-the-coppadis-study-cohort/. Accessed May 14, 2025.
  • Tweet
  • Email
  • Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-differences-between-parkinsons-disease-motor-phenotypes-results-from-the-coppadis-study-cohort/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley